Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of the American College of Cardiology

• Publication date

  2004-01-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JACC.2003.08.040PMID 14736449
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Changes in vascular morphology associated with the no-reflow phenomenon in ischaemic myocardium

  2004cited by this paper
• Further insights into the no-reflow phenomenon after primary angioplasty in acute myocardial infarction: the role of microthromboemboli.

  2003cited by this paper
• Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.

  2002cited by this paper
• Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.

  2002cited by this paper
• Contrast echocardiography can assess risk area and infarct size during coronary occlusion and reperfusion: experimental validation.

  2002cited by this paper
• Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion.

  2001cited by this paper
• Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.

  2001cited by this paper
• Quantitative assessment of myocardial perfusion during graded coronary stenosis by real-time myocardial contrast echo refilling curves.

  2001cited by this paper
• Multiple endothelial injury in epicardial coronary artery induces downstream microvascular spasm as well as remodeling partly via thromboxane A2.

  2001cited by this paper
• Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy.

  2001cited by this paper
• Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention: Results of the GOLD (AU-Assessing Ultegra) Multicenter Study

  2001cited by this paper
• Eptifibatide and 7E3, but Not Tirofiban, Inhibit &agr;v&bgr;3 Integrin–Mediated Binding of Smooth Muscle Cells to Thrombospondin and Prothrombin

  2001cited by this paper
• Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention.

  2001cited by this paper
• Synergy between intracoronary stenting and abciximab in improving angiographic and clinical outcomes of primary angioplasty in acute myocardial infarction.

  2000cited by this paper
• Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial.

  2000cited by this paper
• Recognition of the importance of embolization in atherosclerotic vascular disease.

  2000cited by this paper
• Achieving tissue-level perfusion in the setting of acute myocardial infarction.

  2000cited by this paper
• Ischemia-Reperfusion Injury at the Microvascular Level: Treatment by Endothelin A–Selective Antagonist and Evaluation by Myocardial Contrast Echocardiography

  2000cited by this paper
• Platelet Glycoprotein IIb/IIIa Receptor Inhibitor Preserves Coronary Flow Reserve During Progressive Coronary Arteriostenosis in Swine

  2000cited by this paper
• Real‐Time Contrast Echo Assessment of Myocardial Perfusion at Low Emission Power

  1999cited by this paper
• Real-time visualization of myocardial perfusion and wall thickening in human beings with intravenous ultrasonographic contrast and accelerated intermittent harmonic imaging.

  1999cited by this paper
• Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and s

  1999cited by this paper
• Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction.

  1998cited by this paper
• Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

  1998cited by this paper
• Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group.

  1997cited by this paper
• Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction.

  1996cited by this paper
• Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction.

  1996cited by this paper
• Adhesion Receptors as Therapeutic Targets

  1995cited by this paper
• Ability of the no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow-up.

  1995cited by this paper
• Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.

  1995cited by this paper
• Microvascular compression during myocardial ischemia: mechanistic basis for no-reflow phenomenon.

  1994cited by this paper
• Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty.

  1994cited by this paper
• In vivo angiographic pathoanatomy of unstable angina: twenty years later.

  1989cited by this paper
• Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion.

  1988cited by this paper
• Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: critical importance of the timing of treatment.

  1985cited by this paper
• Enhancement of salvage of reperfused myocardium by early beta-adrenergic blockade (timolol).

  1984cited by this paper
• The injury-spasm (ischemia-induced hemostatic vasoconstrictive) and vascular autoregulatory hypothesis of ischemic disease. Resistance vessel-spasm hypothesis of ischemic disease.

  1982cited by this paper
• Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique.

  1981cited by this paper
• The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

  1974cited by this paper

• Targeting high-mobility-group-box-1-mediated inflammation: a promising therapeutic approach for myocardial infarction

  2024cites this paper
• Intracoronary Versus Intravenous Low-Dose Tirofiban in Patients With ST-Elevation Myocardial Infarction: A Meta-Analysis of Randomised Controlled Trials.

  2024cites this paper
• Tirofiban on Fully Recanalized Stroke with Thrombectomy: A Propensity Score Matching Analysis

  2024cites this paper
• Myocardial Ischemia–Reperfusion Injury: Unraveling Pathophysiology, Clinical Manifestations, and Emerging Prevention Strategies

  2024cites this paper
• Ticagrelor vs. clopidogrel for coronary microvascular dysfunction in patients with STEMI: a meta-analysis of randomized controlled trials

  2023cites this paper
• What do we know about platelets in myocardial ischemia-reperfusion injury and why is it important?

  2023cites this paper
• Impact of maintenance dose of eptifibatide in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention

  2023cites this paper
• The Association of Plasma Osmolarity with No-Reflow in Patients with ST Elevation Myocardial Infarction: A Retrospective Cohort Study

  2023cites this paper
• Reperfusion Cardiac Injury: Receptors and the Signaling Mechanisms

  2022cites this paper
• Intracoronary pharmacological therapy versus aspiration thrombectomy in STEMI (IPAT-STEMI): A systematic review and meta-analysis of randomized trials

  2022cites this paper
• Glycoprotein IIb/IIIa inhibitor use in cardiogenic shock complicating myocardial infarction: The Portuguese Registry of Acute Coronary Syndromes.

  2022cites this paper
• No-reflow phenomenon and reperfusion injury. Mechanisms and treatment

  2022cites this paper
• Primary Percutaneous Coronary Intervention with High-Bolus Dose Tirofiban: The FASTER (Favorite Approach to Safe and Effective Treatment for Early Reperfusion) Multicenter Registry

  2022cites this paper
• Intracoronary Versus Intravenous Administration of Glycoprotein IIb/IIIa inhibitors in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention

  2021influential citation
• Evaluating the Role of Deferred Stenting in ST-Segment Elevation Myocardial Infarction Patients Presented with High Thrombus Burden: A Systematic Review and Meta-Analysis

  2021cites this paper
• Effect of GP IIb/IIIa inhibitor duration on the clinical prognosis of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction with no-/slow-reflow phenomenon.

  2021cites this paper
• Myocardial preservation during primary percutaneous intervention: It's time to rethink?

  2021cites this paper
• Targeted pharmacotherapy for ischemia reperfusion injury in acute myocardial infarction

  2020cites this paper
• Reperfusion injury as a target for diminishing infarct size.

  2020cites this paper
• Effect of intracoronary tirofiban following aspiration thrombectomy on infarct size, in patients with large anterior ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

  2020cites this paper
• Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution

  2020influential citation
• HSOA of Cardiology: Study & Research Effect of Intra-Coronary (IC) Tirofiban Following Aspiration Thrombectomy on Infarct Size, in Patients with Large Anterior STEMI undergoing Primary PCI

  2019cites this paper
• Clinical outcome of intracoronary versus intravenous high-dose bolus administration of tirofiban in diabetic patients undergoing primary percutaneous coronary intervention.

  2019cites this paper
• Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target

  2019cites this paper
• The effect of intracoronary versus intralesional injection of eptifibatide on myocardial perfusion outcomes during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction; A randomized clinical trial study

  2019cites this paper
• Effect of Platelet GPIIb/IIIa Receptor Blockade With MK383 on Infarct Size and Myocardial Blood Flow in a Canine Reocclusion Model

  2018cites this paper
• Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction?

  2018cites this paper
• Myocardial Infarction: An Overview of STEMI and NSTEMI Physiopathology and Treatment

  2018cites this paper
• Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non‐ST‐segment elevation acute coronary syndrome

  2018cites this paper
• Las técnicas de imagen en cardiología: la respuesta actual a los interrogantes de siempre

  2017cites this paper
• Effects of liraglutide on no-reflow in patients with acute ST-segment elevation myocardial infarction.

  2016cites this paper
• No-Reflow Phoenomenon by Intracoronary Thrombus in Acute Myocardial Infarction

  2016cites this paper
• Tirofiban induces vasorelaxation of the coronary artery via an endothelium-dependent NO-cGMP signaling by activating the PI3K/Akt/eNOS pathway.

  2016cites this paper
• Anti-platelet therapy in small animal medicine.

  2016cites this paper
• valuation of Cardioprotective Effects f Recombinant Soluble P-Selectin lycoprotein Ligand-Immunoglobulin in yocardial Ischemia-Reperfusion Injury by eal-Time Myocardial Contrast Echocardiography

  2016cites this paper
• Comprehensive assessment of microcirculation after primary percutaneous intervention in ST-segment elevation myocardial infarction: insight from thermodilution-derived index of microcirculatory resistance and coronary flow reserve

  2015cites this paper
• Effect of the Glycoprotein IIb/IIIa Inhibitor Tirofiban on Concentrations of Whole Blood Choline in Acute Coronary Syndromes

  2015cites this paper
• Signalling pathways and mechanisms of protection in pre‐ and postconditioning: historical perspective and lessons for the future

  2015cites this paper
• 2D- STI Quantitative Analysis of PCI Postoperative Patients with the Myocardial Perfusion Change and its Clinical Significance

  2015cites this paper
• Combined Cardioprotectant and Antithrombotic Actions of Platelet P2Y12 Receptor Antagonists in Acute Coronary Syndrome

  2014cites this paper
• Monitoring the Sequelae of Coronary Microembolization on Myocardium Using Noninvasive Imaging (Review)

  2014cites this paper
• CMR assessment of microvascular obstruction in STEMI: ready for prime time?

  2014cites this paper
• Pharmacological approaches to coronary microvascular dysfunction.

  2014cites this paper
• Comparing the effect of clopidogrel versus ticagrelor on coronary microvascular dysfunction in acute coronary syndrome patients (TIME trial): study protocol for a randomized controlled trial

  2014cites this paper
• Treatment of CMD in Obstructive CAD

  2014cites this paper
• Two Classes of Anti-Platelet Drugs Reduce Anatomical Infarct Size in Monkey Hearts

  2013cites this paper
• Coronary No-Reflow Following Percutaenous Coronary Intervention

  2013cites this paper
• Spontaneous and Procedural Plaque Embolisation in Native Coronary Arteries: Pathophysiology, Diagnosis, and Prevention

  2013cites this paper
• Effects of tirofiban on the reperfusion-related no-reflow in rats with acute myocardial infarction

  2013cites this paper
• Triple Therapy Greatly Increases Myocardial Salvage During Ischemia/Reperfusion in the in situ Rat Heart

  2013cites this paper
• Modulation of individual susceptibility to the no-reflow phenomenon after acute myocardial infarction.

  2013cites this paper
• Platelet P2Y12 Blockers Confer Direct Postconditioning-Like Protection in Reperfused Rabbit Hearts

  2013cites this paper
• Therapy against ischemic injury.

  2013cites this paper
• Therapy against reperfusion-induced microvascular injury.

  2013cites this paper
• Outcome after percutaneous coronary intervention

  2013cites this paper
• Intracoronary versus intravenous high-dose bolus plus maintenance administration of tirofiban in patients undergoing primary percutaneous coronary intervention for acute ST elevation myocardial infarction

  2012cites this paper
• Microvascular Effect of Intracoronary Eptifibatide in Acute Myocardial Infarction

  2012cites this paper
• Echocardiography in Myocardial Reperfusion Injury

  2012cites this paper
• THE SECRETOME OF MONONUCLEAR CELLS AS A THERAPEUTIC TOOL IN MYOCARDIAL INFARCTION AND MYOCARDITIS : AN EXPERIMENTAL STUDY

  2012cites this paper
• Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation

  2012cites this paper
• Bradykinin-induced leukocyte- and platelet-endothelium interactions in the cerebral microcirculation.

  2012cites this paper
• Imaging the Myocardial Microcirculation Post-Myocardial Infarction

  2012cites this paper
• The assessment of microvascular injury in patients undergoing emergency PCI for ST - elevation myocardial infarction

  2012cites this paper
• An Overview of the Consequences of Distal Coronary Microembolization on Left Ventricular Function, Perfusion and Viability

  2011cites this paper
• Assessment of injury in reperfused acute myocardial infarction using cardiovascular magnetic resonance imaging

  2011cites this paper
• Management of the no-reflow phenomenon.

  2011cites this paper
• Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction

  2011cites this paper
• Incidence and predictors of microvascular dysfunction assessed by the index of microcirculatory resistance following primary PCI for ST-elevation myocardial infarction.

  2011cites this paper
• Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach.

  2010cites this paper
• Relationship between no-reflow phenomenon and serotonin levels in patients with acute ST-elevation myocardial infarction who underwent primary percutaneous intervention.

  2010cites this paper
• Microvascular obstruction: underlying pathophysiology and clinical diagnosis.

  2010cites this paper
• No-reflow protection and long-term efficacy for acute myocardial infarction with Tongxinluo: a randomized double-blind placebo-controlled multicenter clinical trial (ENLEAT Trial).

  2010cites this paper
• Therapeutic advances in myocardial microvascular resistance: unravelling the enigma.

  2010cites this paper
• Underlying Pathophysiology and Clinical Diagnosis

  2010cites this paper
• Perfusion assessed by real-time contrast echocardiography correlates with clinical and echocardiographic parameters in patients with first STEMI treated with PCI – 6-month follow-up

  2010cites this paper
• Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration

  2009cites this paper
• Myocardial contrast echocardiography in ST elevation myocardial infarction: ready for prime time?

  2008influential citation
• Pharmaceutical interventions for the management of no-reflow.

  2008cites this paper
• Myocardial perfusion assessed by contrast echocardiography correlates with angiographic perfusion parameters in patients with a first acute myocardial infarction successfully treated with angioplasty.

  2008cites this paper
• Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction.

  2008cites this paper
• The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention.

  2008cites this paper
• Intracoronary adenosine improves myocardial perfusion in late reperfused myocardial infarction.

  2008cites this paper
• Thrombus aspiration during percutaneous coronary intervention.

  2008cites this paper
• Thrombus aspiration during percutaneous coronary intervention.

  2008cites this paper
• Three-dimensional reconstruction of coronary arteriole plexus image by contrast echocardiography using a high-frequency transducer.

  2008cites this paper
• Isolated systolic blood pressure measurement.

  2008cites this paper
• Selective intracoronary administration of nitroprusside before balloon dilatation prevents slow reflow during percutaneous coronary intervention in patients with acute myocardial infarction.

  2007cites this paper
• Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?

  2007cites this paper
• Autologous bone-marrow stem cells for myocardial infarction.

  2006cites this paper
• Upstream/downstream glycoprotein IIb/IIIa in non-ST-segment elevation myocardial infarction.

  2006cites this paper
• The Drug Discovery and Development Proces: Opportunities and Challenges for MR Techniques

  2006cites this paper
• Different Effects of Adenosine and Calcium Channel Blockade on Myocardial No-Reflow after Acute Myocardial Infarction and Reperfusion

  2006cites this paper
• Effect of Tirofiban Therapy on ST Segment Resolution and Clinical Outcomes in Patients with ST Segment Elevated Acute Myocardial Infarction Undergoing Primary Angioplasty

  2006cites this paper
• Imaging microvascular obstruction and its clinical significance following acute myocardial infarction

  2006cites this paper
• No-reflow phenomenon and prognosis in patients with acute myocardial infarction

  2006cites this paper
• Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions: the EVEREST trial.

  2006cites this paper
• Zespół upośledzonej perfuzji tkankowej u chorego poddanego planowej interwencji wieńcowej w obrębie zwężenia we wcześniej implantowanym stencie No-reflow phenomenon occurring during elective angioplasty performed due to in-stent restenosis - a case report

  2006cites this paper
• Human rights in China.

  2006cites this paper
• Final myocardial blush grade predicts troponin I elevation in unstable angina patients undergoing percutaneous intervention.

  2006cites this paper
• The effect of glycoprotein IIb/IIIa inhibition on ST-segment resolution following successful primary percutaneous coronary interventions

  2005cites this paper